Skip to content

Drug interactions

Golimumab + Rozanolixizumab

Severity: Moderate

Golimumab and Rozanolixizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rozanolixizumab blocks the neonatal Fc receptor, which normally recycles IgG molecules and prolongs their half-life. Golimumab is an IgG1 monoclonal antibody, so its clearance could increase and exposure and efficacy fall.

What this interaction means in plain words

Golimumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Golimumab belongs to Musculoskeletal; Rozanolixizumab belongs to Miscellaneous.

Evidence level: Low

Why it happens

FcRn blockade by rozanolixizumab increases catabolism of IgG-based drugs such as golimumab.

What to do

Monitor for loss of golimumab efficacy during and after rozanolixizumab cycles. If disease control worsens, consider alternative therapy or timing doses away from rozanolixizumab treatment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Golimumab and Rozanolixizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Golimumab with Rozanolixizumab?

MediHelp rates the interaction as moderate. Golimumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which normally recycles IgG molecules and prolongs their half-life. Golimumab is an IgG1 monoclonal antibody, so its clearance could increase and exposure and efficacy fall.

How serious is the interaction between Golimumab and Rozanolixizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for loss of golimumab efficacy during and after rozanolixizumab cycles. If disease control worsens, consider alternative therapy or timing doses away from rozanolixizumab treatment.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in